Go Back

Company or ticker...

Protagonist Therapeutics

Protagonist develops peptide-based medicines for immune, blood, and inflammatory diseases.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

PTGX

7.8B

105.8

n/a

40.84%

Key Facts

M. Cap

PS

PE

YTD

7.8B

105.8

n/a

40.84%

10MA

20MA

50MA

200MA

$PTGX

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

Join Now

Join Now